Doufekas et al. [35] initially analyzed over 27,000 CpG sites in endometrial cancers and normal endometrial tissue, and then developed a quantitative PCR-based GALR1 methylation assay to test vaginal swabs from 79 women who had postmenopausal bleeding. The gene discussed is GALR1; the disease is endometrial cancer.